Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple MyelomaJesús F. San Miguel, Hermann Einsele, Philippe Moreau et al.|New England Journal of Medicine|2023Cited by 719
Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myelomaGils Roex, Sébastien Anguille, Marijke Timmers et al.|Journal of Hematology & Oncology|2020Cited by 183
Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation AntigenMarijke Timmers, Sébastien Anguille, Gils Roex et al.|Frontiers in Immunology|2019Cited by 90
Chimeric antigen receptor clustering via cysteines enhances T-cell efficacy against tumorYuedi Wang, Yiwei Chu, Yiyuan Gao et al.|Cancer Immunology Immunotherapy|2022Cited by 18